With close to 7% of its net sales earmarked for R&D and a large international footprint, PCAS is the preferred industrial partner for market-leading major global groups. The company offers a growing range of proprietary products and solutions in leading-edge segments and also includes very high-potential subsidiary: Protéus in biotechnology. Boasting especially high standards, PCAS generated net sales of €2194,1 million in 2020 and employs more than 1071 people in six countries.
Year founded1962
Served areaWorldwide
Headcount1,071
Headquarters21 Chemin de la Sauvegarde, 69134 Ecully Cedex – France
15,141,725
IPOOct. 1, 2014
Stock exchange(s)Euronext Paris